F J Van Spronsen - JoVE Visualize

Showing results (31-40 of 72) with videos related to

Pageof 8

Sort By:

Annals of Nutrition & Metabolism|December 5, 2012

Adherence issues in inherited metabolic disorders treated by low natural protein dietsA MaCdonald, M van Rijn, F Feillet, et al.

Neuropsychologia|October 12, 2001

Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrationsS C J Huijbregts, L M J de Sonneville, R Licht, et al.

The American Journal of Clinical Nutrition|December 1, 1996

Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuriaF J van Spronsen, T van Dijk, G P Smit, et al.

Orphanet Journal of Rare Diseases|February 17, 2019

Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKUA Daly, S Evans, S Chahal, et al.

Brain & Development|March 11, 2008

MR spectroscopy of the brain in Leigh syndromeP E Sijens, G P A Smit, L A Rödiger, et al.

Hepatology (Baltimore, Md.)|November 1, 1994

Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatmentF J van Spronsen, Y Thomasse, G P Smit, et al.

Placenta|March 23, 2004

Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis?M J Leistra-Leistra, A Timmer, F J van Spronsen, et al.

Journal of Inherited Metabolic Disease|August 31, 2023

Food or medicine? A European regulatory perspective on nutritional therapy products to treat inborn errors of metabolismN N Stolwijk, A M Bosch, N Bouwhuis, et al.

Orphanet Journal of Rare Diseases|January 7, 2021

Patient's thoughts and expectations about centres of expertise for PKUA M J van Wegberg, A MacDonald, D Abeln, et al.

Journal of Inherited Metabolic Disease|January 1, 1993

Hereditary tyrosinaemia type I: a long-term study of the relationship between the urinary excretions of succinylacetone and delta-aminolevulinic acidH Schierbeek, G J Beukeveld, H van Faassen, et al.

Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:

Pageof 8

Annals of Nutrition & Metabolism|December 5, 2012

Adherence issues in inherited metabolic disorders treated by low natural protein dietsA MaCdonald, M van Rijn, F Feillet, et al.

Neuropsychologia|October 12, 2001

Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrationsS C J Huijbregts, L M J de Sonneville, R Licht, et al.

The American Journal of Clinical Nutrition|December 1, 1996

Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuriaF J van Spronsen, T van Dijk, G P Smit, et al.

Orphanet Journal of Rare Diseases|February 17, 2019

Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKUA Daly, S Evans, S Chahal, et al.

Brain & Development|March 11, 2008

MR spectroscopy of the brain in Leigh syndromeP E Sijens, G P A Smit, L A Rödiger, et al.

Hepatology (Baltimore, Md.)|November 1, 1994

Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatmentF J van Spronsen, Y Thomasse, G P Smit, et al.

Placenta|March 23, 2004

Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis?M J Leistra-Leistra, A Timmer, F J van Spronsen, et al.

Journal of Inherited Metabolic Disease|August 31, 2023

Food or medicine? A European regulatory perspective on nutritional therapy products to treat inborn errors of metabolismN N Stolwijk, A M Bosch, N Bouwhuis, et al.

Orphanet Journal of Rare Diseases|January 7, 2021

Patient's thoughts and expectations about centres of expertise for PKUA M J van Wegberg, A MacDonald, D Abeln, et al.

Journal of Inherited Metabolic Disease|January 1, 1993

Hereditary tyrosinaemia type I: a long-term study of the relationship between the urinary excretions of succinylacetone and delta-aminolevulinic acidH Schierbeek, G J Beukeveld, H van Faassen, et al.

Pageof 8